Pediatric outpatient sedation
Conditions
Interventions
Remimazolam group:Remimazolam was injected at 0.3mg/kg
Propofol Group:Propofol was injected at 3mg/kg
Sponsors
Maternal and Child Health Hospital of Hubei Province
Eligibility
Sex/Gender
All
Age
3 Years to 10 Years
Inclusion criteria
Inclusion criteria: (1) Informed consent for sedation must be signed by the legal guardians (2) If intranasal dexmedetomidine sedation fails to meet the required depth after 30 minutes of medication or if the child wakes up during the examination, resulting in examination failure. (3) American Society of Anesthesiologists (ASA) grade ?-? is required. (4) Children aged between 3 and 10 years old are eligible. (5) No recent history of sedative use is allowed. (6) There should be no history of allergy to anesthetic drugs. (7) The fasting and water deprivation time must meet the requirements. (8) Body mass index (BMI) should be less than 25.
Exclusion criteria
Exclusion criteria: 1) The family members of the children declined to provide informed consent for their participation in the trial. 2) Subjects with metal implants present in their bodies are excluded from the study. 3) Individuals with a documented history of allergic reactions to anesthetic drugs, active ingredients, and excipients are ineligible for inclusion. 4) Patients with severe congenital heart disease or abnormal liver and kidney function are not eligible for enrollment. 5) Children diagnosed with gastroesophageal reflux will be excluded from the study population. 6) The presence of conscious disturbance symptoms will result in exclusion from participation. 7) Individuals with a medical history of nervous system disorders and mental illness will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate ;SpO2; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood Pressure; | — |
Countries
china
Contacts
Public ContactChengJing Le
Maternal and Child Health Hospital of Hubei Province
Outcome results
None listed